-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RapBdEuo+vEBte9px8J3JjGPzMfqCE7AFVAoHJSgM0JbwQL4QQ4ell7VMc072rYc 7zZ6y7cjUadl96elEVHDsA== 0001050234-05-000052.txt : 20050418 0001050234-05-000052.hdr.sgml : 20050418 20050418100142 ACCESSION NUMBER: 0001050234-05-000052 CONFORMED SUBMISSION TYPE: 10KSB PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041231 FILED AS OF DATE: 20050418 DATE AS OF CHANGE: 20050418 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DIATECT INTERNATIONAL CORP CENTRAL INDEX KEY: 0000319124 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 820513109 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10KSB SEC ACT: 1934 Act SEC FILE NUMBER: 000-10147 FILM NUMBER: 05755521 BUSINESS ADDRESS: STREET 1: 875 SOUTH INDUSTRIAL PARKWAY CITY: HEBER STATE: UT ZIP: 84032 BUSINESS PHONE: 435-654-4370 MAIL ADDRESS: STREET 1: 875 SOUTH INDUSTRIAL PARKWAY CITY: HEBER STATE: UT ZIP: 84032 FORMER COMPANY: FORMER CONFORMED NAME: SAN DIEGO BANCORP DATE OF NAME CHANGE: 19931124 10KSB 1 form10ksb.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION







UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


2004 10KSB

(Mark One)


[ X ]

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the fiscal year ended December 31, 2004


OR

[     ]

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the transition period from _______________ to _______________________



Commission File Number: 0-10147



DIATECT INTERNATIONAL CORPORATION

_______________________________________________________________________

(Exact name of registrant as specified in charter)



California

82-0513109

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer Identification Number)



875 S Industrial Parkway, Heber City, Utah 84032

_______________________________________________________________________

(Address of principal executive offices and zip code)


Issuer’s telephone number, including area code: (435) 654-4370


Securities registered pursuant to section 12(b) of the Act:

Title of each class

Name of each exchange on which registered

N/A

N/A



Securities registered pursuant to section 12(g) of the act:


Common Stock, No Par Value

(Title of Class)


Check whether the issuer (1) filed all reports required to be filed by section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. (1) Yes [X] No [   ] (2) Yes [X] No [   ]


Check if disclosure of delinquent filers in response to Item 405 of Regulation S-B is not contained in this form, and no disclosure will be contained, to the best of the registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-KSB or any amendment to this Form 10-KSB. [X]


State the issuer's revenues for its most recent fiscal year:  $ 665,676


State the aggregate market value of the voting stock held by non-affiliates of the registrant. At April 15, 2005, the aggregate market value of our voting stock held by non-affiliates was $5,574,257 based on 79,632,241 shares held by non-affiliates.  The average of the bid and asked price of our stock on April 15, 2005, was $0.07 per share.


At April 15, 2005, we had  98,825,041 shares of common stock, no par value, issued and outstanding.


DOCUMENTS INCORPORATED BY REFERENCE


List hereunder the following documents if incorporated by reference and the part of the form 10_KSB (e.g., part I, part II, etc.) into which the document is incorporated: (1) Any annual report to security holders; (2) Any proxy or other information statement; and (3) Any prospectus filed pursuant to rule 424(b) or (c) under the Securities Act of 1933:  None





















PART I

ITEM 1.  BUSINESS



General


Diatect International Corporation was incorporated in California in May 19, 1979. We produce a variety of insecticides that  utilize so called "natural-killing agents" which are non-toxic to the environment as well as humans and other warm-blooded animal life.  Some of these materials have been used separately for years as adequate alternatives to hazardous chemical insecticides.  By combining these materials together in our products, we have created a powerful synergy that leads to more effective insect control than they can provide individually.


Over the past decade, chemical companies have voluntarily dropped the registration of approximately 93 active ingredients and 6,100 pesticide products that were in use at the time of cancellation.  Additionally, since insecticides were first used in the 1940's, more than 600 insect species have developed resistance to many synthetic pesticides, leading the industry to constantly search for new products. Our products differ in that they are natural and non-toxic, and insects have not shown to develop a resistance thereto.


We have obtained five EPA registrations and nine retail labels necessary for the production and marketing of insect control products. The approval by the EPA of our labels represents an important asset of the Company since EPA approval can be a lengthy and expensive process. Due to the length of time required to obtain EPA approval for our labels, we did not begin commercial marketing of our products until the later part of 2001.


In an effort to increase sale, we implemented a fund raising program commencing in 2002 whereby our most popular product, Fire Ant, was sold to numerous chapters of an agricultural organization in the southeastern United States. When collection of accounts receivable did not materialize, we elected to contribute our product rather than force collection and charged uncollected amounts to advertising and promotion expense.


At the end of 2004 the Company had 12 employees.  The Company uses a mix of contract labor and employees in the field to market and sell it’s products to the end user and distributors for retail sales.  At the current time the Company has been no long term contracts with any of it’s distributors.  The company does have a four year history with many of it’s retail customers and over ten years with many of it’s agriculture customers.


We have obtained five EPA registrations and nine retail labels necessary for the production and marketing of insect control products. The approval by the EPA of our labels represents an important asset of the Company since EPA approval can be a lengthy and expensive process. Due to the length of time required to obtain EPA approval for our labels, we did not begin commercial marketing of our products until the later part of 2001.


Starting in early 2004 we began to implement an OTC (over the counter) strategy to increase the sales of the Company.  Part of the strategy is to implement a Fundraiser Program with the FFA Chapters in the Fireant areas of the Unites States.   Also to better increase awareness of our Insecticide products the Company plans to increase it’s trade show schedule for the upcoming years.  


At the end of 2004 the Company had 12 employees.  The Company uses a mix of contract labor and employees in the field to market and sell it’s products to the end user and distributors for retail sales.  At the current time the Company has been no long term contracts with any of it’s distributors.  The company does have a four year history with many of it’s retail customers and over ten years with many of it’s agriculture customers.




During the end of 2002 and continuing into 2003 the company relocated it’s manufacturing facilities from Kansas to Utah.  Also the Company moved it’s headquarters From Idaho to Utah, to better control overhead and the manufacturing process the Company has combined all of its business entities under one roof in Heber City, Utah.


Research and Development


The Company has signed an agreement with a Chemist to evaluate a new strand of extended release Plant nutrients that if proven successful would have a significant impact on the companies product lines.  At the current time the company feels that there will not be realization of increased revenue until 2005/2006.


Marketing/Sales


In addition to the ongoing marketing and sales programs the Company has added the following two programs “Got bugs Fundraiser”, “Direct Market Infomercial”.  The “Gotbugs fundraiser utilizes the FFA chapters within Fireant states to sell Results Fireant for a fundraiser to help provide funding for the educational programs within the FFA Chapters.  Although this program has been well received the final outcome has not been determined.  “Direct Market Infomercial” The Company has started airing in certain regions of the Fireant area it’s infomercial direct to consumer, the company can not forecast any sales projections at this time.


The company has signed a distribution agreement with ITB.  ITB has existing contacts within the Pest Control Market.  ITB believes that Diatect’s product would make a good addition to the products that the PCO will use to combat home pests.  The company has started a relationship with a Company in Germany for the distribution of it’s product line.  At this time the international effort is in the preliminary stages and will continue for many years.


Products


Management recognizes the future demand for environmentally acceptable insecticide products in all agriculture retail, and organic industries worldwide.  Our business plan calls for formulations which are natural in composition; components which, as stand-alone insecticides, non-toxic, user and Eco-sensitive, yet cost-effective and they work.


The active ingredients used in our products are diatomaceous earth (“DE”), pyrethrin (a natural extract chemical) and pypernyl butoxide (“PBO” a chemical agent).  We combine DE, pyrethrin and PBO by using surfactants to ensure a good mix and greatly increase effectiveness and persistence.  The combination of these active ingredients results in a compound much more effective than each ingredient individually.  When using the ingredients together, DE breaks down the chitin, allowing the pyrethrin to act on an insect’s nerve cells directly.  The pyrethrin does not evaporate as quickly and is released for hours rather than minutes.  PBO acts as a synergist and increases effectiveness of the pyrethrin by as much as ten times.


Our products consist of five fully registered EPA labels and nine retail labels.  An EPA registration allows the Company to manufacture a product and place it into a retail package for resale.


EPA Registrations

1.  42850-1

2.  42850-2

3.  42850-3

4.  42850-4

5.  42850-5


Retail Registrations


1.

Diatect II is sold in the agriculture market. The insecticide is marketed as “Diatect II Multi-Purpose Insect control.”  Diatect II is used in a wide variety of areas, e.g., edible growing crops, animal quarters, livestock, ornamentals, etc.


2.

Diatect III is distributed and sold in the commercial; industrial; and government markets as “Diatect III Insect Control.”  This insecticide is approved by the EPA for use in a wide variety of areas, e.g., schools, parks, rest stops, roadways, childcare facilities, rest homes, eating establishments, all public places, etc.


3.

Diatect V is a product that was designed and formulated to meet the needs of the organic food industry which requires insecticides with no synthetic ingredients.  Diatect V is sold and distributed to the commercial grower, home owner, and gardener.


4.

Results Ant & Insect is a domestic homeowner product which controls ants, aphids, caterpillars, leafhoppers, lice, mites, mosquitoes, ticks, and other insects.


5.

Results Fireant is applied directly to fire ant mounds and provides quick, effective control in eliminating these aggressive, dangerous pests.  

6.

Results Indoor controls roaches, fleas, ants, silverfish, crickets, bedbugs, box elder bugs, and other insects.  It is designed for use under sinks, behind furniture, in air vents, under tile, and in stairwells and basements.


7.

Results Tomato & Garden protects garden plants from many varieties of worms, beetles, leafhoppers, stink bugs, squash vine borers, and other insects.


8.

Results Rose & Floral protects azaleas, begonias, African violets, chrysanthemums, dogwood, elm, roses, tulips, and many other plants.  It also destroys insects such as mealy bugs, fruit flies, white flies, and caterpillars that ruin the beauty of garden flowers and plants.


9.

Results Pet Powder This product is a stand-alone product for use on pet pests for home owners, kennels, boarding facilities, veterinary clinics and other animal facilities.


We believe the Diatect and Results products are far more effective than major competitive synthetic chemical products.


Regulatory Approval


In general all insecticides, purchased in stores today must, have EPA-approved labels that disclose various required information about the product.  These insecticide labels provide an extensive amount of information and indicate that the insecticide has been tested, evaluated, and regulated by the EPA.  In fact, no insecticides can be legally registered, much less sold, without going through these procedures.


As previously stated, all new insecticides must be "registered" with the EPA, which specifies the conditions of their use as part of its mandate under the Federal Insecticide, Fungicide and Rodenticide Act ("FIFRA").  An insecticide user or manufacturer who fails to comply with FIFRA restrictions risks enforcement actions from both the EPA and state authorities.  Our products comply with FIFRA restrictions and are registered with the EPA, as well as the states into which we sell into.


The cost of developing a new chemical for registration has also risen enormously in recent years, partially because of expensive tests required to show that the chemical poses low environmental and human health risks.  The typical pesticide is put through more than hundreds of tests and approval can take more than six to eight years, and can cost up to 40 million dollars.   Once approved, labeling instructions must be followed for proper use, handling, storage and disposal. We believe the effect of these tighter restrictions and the removal of these active ingredients has opened the door for our products.


Competition in the Insecticide Industry


The principal players in the U.S. insecticide industry, are major companies.  Most companies  have more extensive resources than we do and have established product recognition.  We believe, however, that by focusing on more natural, safer, non hazardous, eco-sensitive insecticides, we are able to acquire market niches which have not been a focus of the larger, better established companies. We believe we have an advantage in the products and market niche we have identified in that we have already obtained EPA approval of our products and labels.


Board and Management Changes


In 2004, Javvis Jacobson was elected on to the Board of Directors and was nominated for the Audit Chair.


Subsidiaries


At December 31, 2003, we have no active subsidiaries.  



ITEM 2.  PROPERTIES


Diatect International Corporation, 875 South Industrial Parkway, Heber City, Utah 84032.  This facility is a 20,254 square foot class C masonry office/warehouse building on 1.928 acres in the Heber City, Utah Industrial Park.  The Company purchased its facilities on January 17, 2003 at a total cost of $875,500.  Terms of the agreement called for a down payment of $28,500 and a mortgage note of $847,000 bearing interest at a rate of 13% per annum and secured by the related land and building. Interest only payments commenced on February 17, 2003 and will continue on the same day of each succeeding month until January 17, 2005 at which time the mortgage is due.  Interest only payments are approximately $9,200 per month.  The $847,000 mortgage note payable is reflected on the balance sheet under short-term debt at December 31, 2004. During March 2005, the land and building were sold to an u nrelated third party and the proceeds from the sale were use to satisfy the balance due under the mortgage note and other short-term liabilities.



ITEM 3.  LEGAL PROCEEDINGS


Resolved Litigation


Iver J. Longeteig – An obligation that resulted from litigation was satisfied by cash payments in the amount of $6,844 during 2003 and the issuance of 115,000 shares of common stock during 2004, which were value at $21,275, or $0.19 per share, base on the market value of the common stock on the date of the settlement.


Complete Packaging, LLC d.b.a. Compax – On December 2, 2004, a judgment was entered against the Company in the amount of $323,892 plus accrued interest from November 30, 2004. During 2005, the Company entered into a settlement agreement in which the Company agreed to make three $25,000 payments through May 2005 and a lump sum payment of $145,000 in June, 2005. The Company has recorded a short-term note payable of $220,000 at December 31, 2004.


Current Litigation


La Jolla Cove Investors, Inc. – During December 2002, the Company entered into a convertible debenture agreement with La Jolla Cove Investors, Inc., who at the time was the named underwriter (the “Underwriter”) for a planned public offering of the Company’s common stock. The Underwriter advanced the Company $150,000 in 2002 and $100,000 in 2003, which advances were evidenced by a convertible debenture agreement that was to be repaid out of a portion of the proceeds from the public offering. On July 12, 2004, the Underwriter filed a complaint for breach of contract in the State of California claiming a default under the terms of the convertible debenture in the amount of $406,990. On November 18, 2004, prior to the registration statement relating to the public offering being declared effective, the Company withdrew the registration statement. The Underwriter has agreed to s tay all collection efforts pursuant to the complaint until April 14, 2005 and a settlement offer of $230,000 is currently being negotiated. The Company has recorded a liability relative to the convertible debenture agreement of $268,132 in its 2004 financial statements.


Litho-Flexo Graphics, Inc. – The Company claims that this vendor provided defective labels to be used in the packaging of its products and therefore did not pay outstanding invoices in the amount of $72,625. The vendor filed a complaint claiming an amount of $92,478 is due and the Company counterclaimed for damages resulting from the use of the defective labels in excess of $100,000. The Company continues to carry the $72,625 on its financial statements for 2003 and 2004 as a liability.


Robinson Family LLC – On October 1, 2001, the Company executed a $106,000 promissory note bearing interest at 12% per annum that was due on April 1, 2002. The plaintiff filed suit to collect this note and accrued interest. The Company is in the process of negotiating a settlement of the note. The note payable is carried at $126,686 at December 31, 2004.


SPI, LLC – On December 18, 2002 the Company gave an $18,070 promissory note to David J. Stecher, due on demand with interest at 15% per annum. Subsequently the Company made payments reducing the balance for both principal and interest to $16,814. This claim is for the entire principal amount of the note.  In the Company’s financial statements for 2004, a liability in the amount of $16,814 is recorded.


Jared G. Parkinson – Parkinson filed a complaint for $10,000 claiming that the amount of an outstanding note payable is due. The Company contends that a $2,500 payment has been made and that only $7,500 plus accrued interest of $1,334 is due. In the Company’s financial statements for 2004, a liability in the amount of $8,834 has been recorded.


John Chaney – A former employee of the Company has filed a breach of contract claim against the Company in the amount of $6,251. The Company has not accrued any liability for this claim.


Bruce L. Shannon – On August 1, 2001, the Company executed a $200,000 note payable with interest at the rate of 12% per annum, due August 1, 2002 and subsequently extended to May 1, 2005. Mr. Shannon filed suit claiming that this note was not extended. In the Company’s financial statements for 2004, a note payable in the amount of $200,000 and accrued interest in the amount of $80,500 has been recorded.


Threatened Litigation


L. Craig Hunt – Pursuant to the non-payment of a $42,750 promissory note dated August 28, 1996, a judgment was entered against the Company on February 1, 1999 in the amount of $61,543. The plaintiff did not pursue the collection of this judgment and the Company recorded this amount as a gain from extinguishment of debt during 2004. During 2005 the Plaintiff’s estate made demand on the Company for payment of the judgment amount. The Company contends that the period allowed for the collection of the judgment had expired and no further obligation exists.


We are not aware of any other threatened litigation against us.  For additional information see Note 5 to the financial statements.



ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITIES HOLDERS


We did not submit any matters to a vote of our securities holders in the fourth quarter ended December 31, 2004.



PART II

ITEM 5.  MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS


The following table sets forth, for the respective periods indicated, the prices for our common stock in the over-the-counter market as reported by a weekly reporting service and according to the NASD’s OTC Bulletin Board.  The bid prices represent inter-dealer quotations, without adjustments for retail mark-ups, mark-downs or commissions and may not necessarily represent actual transactions.  At April 15, 2005, our common stock was quoted under the symbol “DTCT” and had a high of $0.07 and a low of $0.07.  All bid prices below have been rounded to the nearest whole cent.   During 2003 Diatect International was listed on the Frankfurt & Berlin exchange, WKN 913540 and remain current in its filings.


 

Bid Prices

Fiscal Year Ended December 31, 2004

High

Low


Fourth Quarter

$      0.09

$      0.04

Third Quarter

$      0.14

$      0.07

Second Quarter

$      0.25

$      0.12

First Quarter

$      0.30

$      0.16

   

Fiscal Year ended December 31, 2003

High

Low


Fourth Quarter

$      0.39

$      0.13

Third Quarter

$      0.26

$      0.10

Second Quarter

$      0.24

$      0.10

First Quarter

$      0.23

$      0.11



We have not paid any dividends on our Common Stock, and we do not anticipate that we will pay dividends in the foreseeable future.  The future payment of dividends, on the common stock is within the discretion of the Board of Directors and will depend on our earnings, our capital requirements and financial condition, and other relevant factors.


At April 15, 2005 we had 1,198 shareholders of record based on information provided by our transfer agent.


During the year ended December 31, 2004, the Company issued 5,968,587 shares of its common stock valued at $588,176 in payment of debt and interest, 10,848,356 shares valued at $1,068,443 for services, and 2,736,565 shares for financing costs. These shares were valued at their fair market value on the date of issuance. In addition, the Company sold 7,386,100 shares of common stock at prices ranging from $0.10 to $0.25 per share for cash pursuant to an exemption from registration under Section 4(2) of the Securities Act of 1933, as amended.


ITEM 6.  MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION


Cautionary Statement Regarding Forward-looking Statements


This report may contain “forward-looking” statements.  Examples of forward-looking statements include, but are not limited to: (a) projections of revenues, capital expenditures, growth, prospects, dividends, capital structure and other financial matters; (b) statements of plans and objectives of our management or Board of Directors; (c) statements of future economic performance; (d) statements of assumptions underlying other statements and statements about us and our business relating to the future; and (e) any statements using the words “anticipate,” “expect,” “may,” “project,” “intend” or similar expressions.


General


Throughout years of research and development we have envisioned a business venture built upon the development, production and marketing of a quality line of natural, ecological friendly and high quality insecticide products.  Unfortunately we have lacked the financial resources to compete head-to-head with the large corporations that dominate the industry.  However due to regulatory pressures, public concern for the environment, and our unique products, we feel this is about to change.  We are gaining a strong foothold in niche markets.


In 2003, we placed heavy marketing focus on retail sales of our Fireant product to retail outlets. We successfully increased our customer base and market awareness of our products.  We also restructured our retail sales and support staff in preparation for major marketing efforts in 2004 and 2005.


Over the past several months a new business development team has launched an aggressive campaign to enter a variety of markets with heavy emphasis on retail.


Results of Operations


Year ended December 31, 2004 compared to year ended December 31, 2003


Revenues.  We had revenues of $665,676 and cost of sales of $203,398 with a gross profit of $462,278 for the year ended December 31, 2004, compared to revenues of $732,391 and cost of sales of $872,610 (this includes adjustment of inventory to market value) with a gross loss of $140,219 for the prior year period.  The slight decrease in revenue compared to the prior year reflects the restructuring of our marketing and sales efforts from agriculture and conventional agriculture to the highly lucrative retail and organic markets.  We believe the flat nature of sales is a reflection of the outdated marketing focus which has been redesigned.



Operating Expenses.  For fiscal year ended December 31, 2004, we had total operating expenses of $2,797,873 compared to $3,646,177 for the prior year, an overall decrease of $848,304.  The overall decrease in operating expenses is primarily attributable to the decrease of employee compensation, advertising and promotion, however increases occurred in consulting fees.  Interest expenses decreased between the two years by $582,296 as a results of converting notes payable into the Company’s common stock.  




Liquidity and Capital Resources


The Company generated revenue of $665,676 and $732,391during the years ended December 31, 2004 and 2003, respectively. However, during the years ended December 31, 2004 and 2003, the Company incurred a net loss of $2,818,583 and $5,162,155, respectively, and had negative cash flows from operating activities of $908,650 and $1,1.756.024, respectively. As of December 31, 2004, the Company had accumulated a deficit of $23,570,770, had a working capital deficiency of $3,101,961 and had a stockholders’ deficit of $2,637,879. The Company’s cash resources consist of collections from customers, debt financing and from the issuance of common stock.


Cash used in operations for the year ended December 31, 2004 was $908,650 compared to $1,756,024 for the prior year.  In 2004 and 2003, our operations were funded primarily by sales of our products, loans and issuance of common stock.


Our cash flow from financing activities provided $992,861 during the year ended December 31, 2004  consisting of $822,423 from the sale of common stock and $273,324, from the issuance of notes payable.  Our cash flows from financing activities during the year ended December 31, 2003 was $1,794,558, consisting of $129,000 from the sale of our common stock and $1,723,487 from the issuance of notes payable.


Subsequent to December 31, 2004, the Company has issued 1,925,000 shares of common stock for cash in the amount of $325,000.




ITEM 7.  FINANCIAL STATEMENTS


Our financial statements are set forth immediately following the signature page to this Form 10-KSB.  (See ITEM 13. EXHIBITS AND REPORTS ON FORM 8-K for Index to Financial Statements.)



ITEM 8.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE


We have had no disagreements with our certified public accountants with respect to accounting practices or procedures or financial disclosure.


 (a) Evaluation of disclosure controls and procedures.

 

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the fiscal year (the “Evaluation Date”). Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of the Evaluation Date, our disclosure controls and procedures were effective in timely alerting them to the material information relating to us (or our consolidated subsidiaries) required to be included in our periodic SEC filings.

 

(b) Changes in internal controls.

 

There were no significant changes made in our internal controls during the period covered by this report or, to our knowledge, in other factors that could significantly affect these controls subsequent to the date of their evaluation.

 

See the Certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.







PART III


ITEM 9.  DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS, AND CONTROL PERSONS; COMPLIANCE WITH SECTION 16(a) OF THE EXCHANGE ACT


The following table sets forth as of March 2, 2004, the name, age and position of each of our executive officers and directors and their respective terms of office.


Name

Age

Position

Director and/or Officer Since


Dave Andrus

40

Director

President

Chairman of the Board

December 1997

December 2004

December 2004

    

John L. Runft

68

Director

February 1995

    

Margie Humphries

55

Corporate Secretary

October 2002

    

M. Stewart Hyndman

48

Director

December 1997

    

Frank Priestly

48

Director

November 2002

     

Michael P. McQuade

48

Director

May 2002

    

Javvis Jacobson

33

Director

March 2004



Our directors serve for a term of one year or until his or her successor is elected at our annual shareholders meeting, subject to removal by our Company's shareholders.  All officers serve at the pleasure of the Board of Directors or until his or her successor is elected at the annual meeting of the Board of Directors.


Set forth below is certain biographical information regarding each of our executive officers and directors.


David H Andrus  joined the Board of Directors in 1997 and assumed the post of President and Board Chairman in December, 2004 when Jay Downs resigned. Dave has over 13 years experience operations and manufacturing.


David H. Andrus began an affiliation with Diatect in 1992.  Dave served in the U.S. Marine Corps for 10 years in the logistics and intelligence field, and was medically retired in 1991.  He formed Venture Creations which performed contract research and development for Enviro-Guard (now Diatect).  As R&D project manager, Dave supervised extensive field trials of the Diatect Insect Control within the poultry industry and for Fireant concerns in that region.  In 1998, Dave became manager of National Diatect, a distributor of Diatect insecticides (later acquired by us).  As technical manager for Diatect, Dave was responsible for all field studies of our product, and was instrumental in our transition from research and development to commercialization.  Since September 2001, Dave has served as Vice-president Reasurch & development, Vice President of Operations, COO.



John L. Runft has been practicing law since 1965, emphasizing business organizations and litigation.  He received his BA from Albertson's College of Idaho in 1962, and his J.D. from the University of Chicago School of Law in 1965 John is a member of the Idaho Bar, and has appeared as lead counsel in litigation or appeals before the United States Court of Appeals for the Federal Circuit, and the United States Supreme Court.  He is a member of the Board of Litigation of the Mountain States Legal Foundation, is a member of the Idaho Law Foundation, served as a Director of the Idaho Community Foundation (1989-1996), and has served as Civilian Aide to the Secretary of the Army of the United States for the State of Idaho (1988-1996).


M. Stewart Hyndman is the President of Magic Miles Ltd; Inc., Meridian, Idaho, an export trading company established in 1995 specializing in the export of agricultural commodities and industrial products.  Following his graduation from the University of Idaho, Stewart has continued to play an active role in industry, agriculture, marketing and business development.


Frank S. Priestly joined the Board of Directors on October 18, 2002.  He has been in the farming business in Idaho since 1970.  He currently serves as President of the Idaho Farm Bureau Federation, Farm Bureau Finance Co., Agricultural and Educational Research Foundation and the Farm Bureau Insurance Companies of Idaho.  He also serves on the Board of Directors for the American Farm Bureau Federation, with an appointment to the executive committee.  He comes to Diatect International with lots of experience in agriculture growing alfalfa, barley, corn and pasture for the family dairy operation.  


Dr. Michael P. McQuade has had a private dental practice since 1987, living in Richmond, Virginia.  He graduated from Virginia Polytechnic Institution & State University with a B.S. in Biology.  He then graduated from the Virginia Commonwealth University as a Doctor of Dental Surgery.  For the last five years Dr. McQuade has worked extensively in the poultry industry particularly in the Northeast as well as the Southeast region of the United States and research universities with respect to our product.


Margie Humphries was appointed Corporate Secretary in October of 2002.  She relocated to Heber, Utah, in September of 2002.  She comes with 25 years of professional work experience.  Starting in December of 1991 until July of 1998, she worked for Wasatch Medical Center.  Responsibilities included the billing and collection process for five physicians and monitoring accounts receivable.  From July of 1998 until March 2002, when she joined Diatect International, she worked full time as a medical transcriber for Utah Valley Regional Medical Center, where she had been appointed a team leader.

Javvis O. Jacobson joined the Board of Directors in 2004.  He is the CFO of Beehive Credit Union in Salt Lake City Utah.  Following his graduation from Weber State University, Javvis joined Deloitte & Touche, a prominent CPA firm, where he spent several years managing audits of financial institutions, health care providers, manufacturing companies, and various other entities.



Involvement in Certain Legal Proceedings


See ITEM 3. LEGAL PROCEEDINGS of this Form 10-KSB.




ITEM 10.  EXECUTIVE COMPENSATION


The following tables set forth certain summary information concerning the compensation paid or accrued for each of our last two completed fiscal years to our chief executive officer and each of our other executive officers that received compensation during such period (as determined at December 31, 2003, the end of our last completed fiscal year):


SUMMARY COMPENSATION TABLE

     

 Long Term Compensation

 

  

 Annual Compensation

 Awards

 Payouts

 

    

 Other

 

 Securities

 

 All

Name and

   

 Annual

 Restricted

 Underlying

 

 Other

Principle

   

 Compensation

 Stock

 Options /

 LTIP

 Compensation

Position

Year

 Salary ($)

 Bonus ($)

 ($)

 Awards ($)

 SARs (#)

 Payouts ($)

 ($)

     

 

 

 

 

Jay W. Downs

    

 

 

 

 

CEO

2004

       114,170

                  -

                       -

                     -

                     -

                     -

           19,810

CEO

2003

       128,980

           9,000

                       -

         108,797

         350,000

                     -

         170,710

CEO

2002

       120,000

           6,739

                       -

                     -

                     -

                     -

                     -

     

 

 

 

 

David Andrus

    

 

 

 

 

CEO

2004

         58,712

           6,657

                       -

                     -

                     -

                     -

         170,290

Vice-President

2003

         99,639

           9,000

                       -

         146,150

                     -

                     -

         134,255

Vice-President

2002

         90,000

           6,739

                       -

                     -

                     -

                     -

                     -




Employment Agreements


David Andrus signed an employment agreement effective December 1, 2004 for a term of two years at an annual salary of $150,000 per year, with a signing bonus of 3,000,000 (non-dilutable , valued at market price) of our restricted common stock.  The agreement includes provisions for a reasonable allowances and a bonus based on 1% of gross sales receipts as determined on a quarterly basis.  Accrued bonuses for 2004 pursuant to his agreement were paid in December 31, 2004.


Jay Downs resigned during the year 2004 all payment and stock options pursuant to his employment agreement were terminated upon his regisnation

.

Board Compensation


Members of the board of directors are compensated for service at a rate of 1,000 shares of stock per month of service.  In 2004, we issued a total of 97,000 shares to the current directors pursuant to this compensation arrangement as follows:


Jay Downs

6,000 shares

Dave Andrus

12,000 shares

John Runft

12,000 shares

Stewart Hyndman

12,000 shares

Michael McQuade

12,000 shares

Frank Priestly

12,000 shares

Javvis Jacobson

19,000 shares

Margie Humphries

12,000 shares



ITEM 11.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT


The following tables set forth as of April 15, 2005, the name and address and the number of shares of our Common Stock, held of record or beneficially by each person who held of record, or was known by us to own beneficially, more than 5% of the 98,825,041 issued and outstanding shares, and the name and share holdings of all officers and directors as a group.







Security Ownership of Certain Beneficial Owners




Title of Class

Name and Position

Of Beneficial Owner

Amount and Nature of Beneficial Ownership


Percent of Class

Common

Philip M. Morrell

7,577,034

7.67

 

Share Holder

  



Security Ownership of Officers and Directors



Title of Class

Name and Position of Officer and Director

Amount and Nature of Beneficial Ownership


Percent of Class


Common

David H Andrus

Director/President

Chairman of the Board

7,017,841

7.10

    

Common

John L. Runft

Director

1,918,040

1.94

    

Common

Javvis Jacobson

Director

            169,000

0.17

    

Common

M. Stewart Hyndman

Director

389,800

0.39

    

Common

Frank Priestly

Director

76,000

0.00

    

Common

Michael P. McQuade

Director

1,500,085

1.52

    

Common

Margie Humphries

Secretary

145,000

0.15


All Officers/Directors as a Group (7 persons)

 

11,215,766

11.27



ITEM 12.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS


Except as indicated below, and for the periods indicted, there were no material transactions, or series of similar transactions, since the beginning of our last fiscal year, or any currently proposed transactions, or series of similar transactions, to which we are a party, in which the amount involved exceeds $60,000, and in which any director or executive officer, or any security holder who is known by us to own of record or beneficially more than 5% of any class of our common stock, or any member of the immediate family of any of the foregoing persons, has an interest.


We have current and long-term notes payable to 29 shareholders totaling $4,057,770 and $2,272,207 as of December 31, 2004 and 2003, respectively.  See Note 3 to the financial statements.


A Director performed legal services for the Company during the years ended December 31, 2004 and 2003. During 2004, 43,750 shares of common stock valued at market ($7,875) were issued in payment for these services and during 2003, 378,322 shares of common stock valued at market ($56,748) were issued in payment for these services.


Certain directors of the Company have extended their credit and guarantees on behalf of the Company. During 2004 and 2003, the Company issued 400,000 shares of common stock valued at $60,000 and 700,000 shares of common stock valued at $105,000, respectively, to compensate these directors. These shares were valued at market value on the dates issued.


RELATED TRANSACTIONS.

 

On August 12, 2003, the Company received a letter of intent from Diatomaceous Earth Deposits of Virginia to purchase 90% of the diatomaceous earth mining site in Oregon. in exchange for a note in the amount of $31.1 million. An agreement for the sale of the property interest was completed on September 10, 2003 by the buyer executing a promissory note in the amount of $31.1 million. The terms of the note require an annual principal payment of $1,945,350 and interest at 8% per annum for 16 years commencing in September 2005. Diatomaceous Earth Deposits of Virginia is co-owned Michael P. McQuade who is an outside director of the Company.  The Company has considered the agreement to be non-substantive as the buyer is thinly capitalized and has only made minimal investments in the property. The Company therefore did not recognize the sale. In December 2004, it was mutually agreed that even t hough the purchaser had spent money to investigate the potential of placing the mining claims into production, such efforts would not be pursued and the Company entered into a termination and release agreement with the purchaser.


Certain Business Relationships


Except as indicated, and for the periods indicated, there were no material relationships regarding officers or directors that exist, or have existed during our last fiscal year.



PART IV


ITEM 13.  EXHIBITS AND REPORTS ON FORM 8-K


(a)(1) Financial Statements. The following financial statements are included in this report:

 

Title of Document

Page

 

Report of Hansen, Barnett & Maxwell, independent registered public accounting firm


Balance Sheets as of December 31, 2004 and 2003


Statements of Operations for the years ended December 31, 2004 and 2003

 

Statements of Stockholders' Deficit for the years ended December 31, 2004 and 2003

 

Statements of Cash Flows for the years ended December 31, 2004 and 2003

 

Notes to Financial Statements, December 31, 2004 and 2003


 

(a)(2) Financial Statement Schedules.

 

Not applicable

 

(b)  The following exhibits are included in this report:

 

Exhibit 31.1 – Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

Exhibit 32.1 – Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

Exhibit 99.1 – Code of Ethics and Business Conduct for Officers, Directors, and Employees

 

(c) Reports on Form 8-K. The following reports on Form 8-K were filed with the Commission during the quarter ended December 31, 2004.


October 28, 2004  

November 5, 2004

December 30, 2004

 



ITEM 14.  CONTROLS AND PROCEDURES



The Company’s board of directors reviews and approves audit and permissible non-audit services performed by its registered public accounting firm, Hansen, Barnett & Maxwell. In its review of non-audit service fees and in its appointment of a registered public accounting firm, the board of directors considered whether such services are compatible with maintaining the authorized independence of the public accountants. All fees for audit and non-audit services that  may be charged by our registered public accounting firm will be pre-approved by the board of directors.

 

Audit Fees

 

This is the first year that Hansen, Barnett & Maxwell is the Company’s registered public accounting firm and no payments have been made to them for the audit of the annual financial statements or for the review of interim financial statements.

 

Audit-Related Fees

 

No other fees have been billed by Hansen, Barnett & Maxwell during the last two fiscal years for assurance or other related services that were reasonably related to the audit of the Company’s financial statements and not reported under “Audit Fees” above.

 

Tax Fees

 

Hansen, Barnett & Maxwell were not engaged by the Company during the last two fiscal years to perform any professional services with respect to the preparation of tax returns or other tax related matters.

 

All Other Fees

 

There were no other fees billed by Hansen, Barnett & Maxwell during the last two fiscal years for products and services provided by them.

 












SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this amended report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:


DIATECT INTERNATIONAL CORPORATION


Date: April 14, 2004


/s/ Dave Andrus, Chief Executive Officer, Principal Accounting Officer


/s/ Margie Humphries Secretary


Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this amended report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:


Date: April 15, 2005


/s/ John L. Runft, Director


/s/  Javvis Jacobson, Director


/s/ David Andrus, Director


/s/ M. Stewart Hyndman, Director


/s/ Frank Priestly, Director


/s/ Michael P. McQuade, Director
















DIATECT INTERNATIONAL CORPORATION

TABLE OF CONTENTS




Page

  

Report of Independent Registered Public Accounting Firm


F-2

  

Balance Sheets – December 31, 2004 and 2003


F-3

  

Statements of Operations for the Years Ended December 31, 2004 and 2003


F-4

  

Statements of Stockholders’ Deficit for the Years Ended

 

  December 31, 2003 and 2004


F-5

  

Statements of Cash Flows for the Years Ended December 31, 2004 and 2003


F-6

  

Notes to Financial Statements


F-8






F-1




HANSEN, BARNETT & MAXWELL

A Professional Corporation

CERTIFIED PUBLIC ACCOUNTANTS

5 Triad Center, Suite 750

Salt Lake City, UT 84180-1128

Phone: (801) 532-2200

Fax: (801) 532-7944

www.hbmcpas.com





REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM



To the Board of Directors and the Stockholders

Diatect International Corporation


We have audited the balance sheets of Diatect International Corporation as of December 31, 2004 and 2003, and the related statements of operations, stockholders’ deficit, and cash flows for the years then ended. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.


We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (U.S). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements.  An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.  We believe that our audits provide a reasonable basis for our opinion.


In our opinion the financial statements referred to above present fairly, in all material respects, the financial position of Diatect International Corporation as of December 31, 2004 and 2003, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.



HANSEN, BARNETT & MAXWELL

Salt Lake City, Utah

April 6, 2005, except for Note 12,

  as to which the date is April 15, 2005





F-2





DIATECT INTERNATIONAL CORPORATION

BALANCE SHEETS


December 31,

2004

 

2003

ASSETS

Current Assets

   

Cash

 $      85,260

 

 $        6,021

Trade accounts receivable, net of allowance for doubtful

   

  accounts of $95,624 and $88,312, respectively

         54,919

 

         93,151

Inventory

       461,911

 

       576,647

Prepaid expenses and other current assets

       150,000

 

       111,000

Total Current Assets

       752,090

 

       786,819

Property and Equipment

     1,242,822

 

     1,269,300

Less: Accumulated depreciation

      (233,499)

 

      (156,490)

Net Property and Equipment

     1,009,323

 

     1,112,810

Intangible Assets - EPA Labels

     1,736,322

 

     1,736,322

Less: Accumulated amortization

      (496,000)

 

      (248,000)

Net Intangible Assets

     1,240,322

 

     1,488,322

Total Assets

 $  3,001,735

 

 $  3,387,951

LIABILITIES AND STOCKHOLDERS' DEFICIT

Current Liabilities

   

Accounts payable

 $     370,789

 

 $  1,177,911

Accrued payroll and related liabilities

       285,590

 

       285,715

Accrued interest payable

       506,924

 

       459,117

Accrued settlement obligations

       418,541

 

       337,229

Accrued royalty payable

               -   

 

       113,623

Capital lease obligation

               -   

 

         13,807

Notes payable - current portion

     2,272,207

 

     1,711,381

Total Current Liabilities

     3,854,051

 

     4,098,783

Long-Term Notes Payable - net of current portion

     1,785,563

 

     1,941,522

Stockholders' Deficit

   

Common stock, no par value; 100,000,000 shares authorized;

   

  88,817,518 shares and 61,877,910 shares outstanding, respectively

   20,784,858

 

   18,099,833

Warrants outstanding

       148,033

 

               -   

Accumulated deficit

  (23,570,770)

 

  (20,752,187)

Total Stockholders' Deficit

   (2,637,879)

 

   (2,652,354)

Total Liabilities and Stockholders' Deficit

 $  3,001,735

 

 $  3,387,951






The accompanying notes are an integral part of these financial statements.


F-3





DIATECT INTERNATIONAL CORPORATION

STATEMENTS OF OPERATIONS



For the Years Ended December 31,

2004

 

2003

 

 

 

 

Revenue

 $    665,676

 

 $    732,391

Cost of Revenue

     (203,398)

 

     (408,749)

Adjustment of Inventory to Market Value

               -   

 

     (463,861)

    

Gross Profit (Loss)

       462,278

 

     (140,219)

    

Expenses

   

Employee compensation

       926,448

 

    1,766,156

Consulting

       728,141

 

       314,230

Depreciation

         87,703

 

         91,877

Amortization of intangible assets

       248,000

 

       248,000

Advertising and promotion

       158,080

 

       536,631

General and administrative

       649,501

 

       689,283

    

Total Expenses

    2,797,873

 

    3,646,177

    

Interest expense

       806,202

 

    1,388,498

    

Loss from Operations

   (3,141,797)

 

   (5,174,894)

    

Gain from Termination of Debt

       323,214

 

         12,739

    

Net Loss

 $(2,818,583)

 

 $(5,162,155)

    

Basic and Diluted Loss per Share

 $        (0.04)

 

 $        (0.11)

    

Weighted-Average Common Shares Outstanding

   75,292,935

 

   49,072,882

 





The accompanying notes are an integral part of these financial statements.


F-4




 DIATECT INTERNATIONAL CORPORATION

STATEMENTS OF STOCKHOLDERS’ DEFICIT



       

 Common

 

 Options and  

   

 Total

   

 Common stock

 

 Stock

 

 Warrants

 

 Accumulated

 

 Stockholders'

 

 

 

 Shares

 

 Amount

 

 Subscribed

 

 Outstanding

 

 Deficit

 

 Deficit

Balance, December 31, 2002

   45,013,414

 

 $  14,971,327

 

 $ (20,000)

 

 $        36,070

 

 $  (15,590,032)

 

 $      (602,635)

Issuance for cash

        580,000

 

          109,000

 

              -   

 

                   -   

 

                     -   

 

          109,000

Exercise of options

     2,350,000

 

          513,720

 

              -   

 

       (203,720)

 

                     -   

 

          310,000

Conversion of notes payable and accrued interest

     2,711,802

 

          626,626

 

              -   

 

                   -   

 

                     -   

 

          626,626

Payment of accrued settlement obligation

        350,000

 

            41,648

 

              -   

 

                   -   

 

                     -   

 

            41,648

Issuance for services

     4,373,962

 

          819,815

 

              -   

 

                   -   

 

                     -   

 

          819,815

Issuance for financing costs

     6,498,732

 

       1,000,617

 

              -   

 

                   -   

 

                     -   

 

       1,000,617

Issuance of warrants for consulting services

                  -   

 

                    -   

 

              -   

 

         184,730

 

                     -   

 

          184,730

Forfeiture of options

                  -   

 

            17,080

 

              -   

 

         (17,080)

 

                     -   

 

                    -   

Reversal of stock subscription

                  -   

 

                    -   

 

      20,000

 

                   -   

 

                     -   

 

            20,000

Net loss

 

                  -   

 

                    -   

 

              -   

 

                   -   

 

       (5,162,155)

 

      (5,162,155)

Balance, December 31, 2003

   61,877,910

 

     18,099,833

 

              -   

 

                   -   

 

     (20,752,187)

 

      (2,652,354)

Issuance for cash

     4,473,600

 

          589,500

 

              -   

 

                   -   

 

                     -   

 

          589,500

Issuance of common stock and warrants for cash

     2,912,500

 

            84,890

 

              -   

 

         148,033

 

                     -   

 

          232,923

Issuance of common stock for notes payable, accounts payable, settlements payable and accrued interest

     5,968,587

 

          588,176

 

              -   

 

                   -   

 

                     -   

 

          588,176

Issuance for services

   10,848,356

 

       1,068,443

 

              -   

 

                   -   

 

                     -   

 

       1,068,443

Issuance for financing costs

     2,736,565

 

          354,016

 

              -   

 

                   -   

 

                     -   

 

          354,016

Net loss

 

                  -   

 

                    -   

 

              -   

 

                   -   

 

       (2,818,583)

 

      (2,818,583)

Balance as of December 31, 2004

   88,817,518

 

 $  20,784,858

 

 $           -   

 

 $      148,033

 

 $  (23,570,770)

 

 $   (2,637,879)



The accompanying notes are an integral part of these financial statements.


F-5





DIATECT INTERNATIONAL CORPORATION

STATEMENTS OF CASH FLOWS


For the Years Ended December 31,

2004

 

2003

Cash Flows from Operating Activities

   

Net loss

 $(2,818,583)

 

 $(5,162,155)

  Adjustments to reconcile net loss to net cash  

   

    used in operating activities:

   

    Gain from debt termination

      (323,214)

 

       (12,739)

    Depreciation and amortization

       335,703

 

       339,877

    Provision for obselete inventory

               -   

 

       463,861

    Loss on disposal of property and equipment

         20,756

 

         36,072

    Issuance of stock for services

       918,443

 

       889,945

    Issuance of stock for finance charges and interest

       354,016

 

     1,000,617

    Changes in operating assets and liabilities

   

      Trade accounts receivable

         38,232

 

       260,762

      Prepaid expenses

       111,000

 

       164,447

      Inventory

       114,736

 

       218,641

      Accounts payable

         92,229

 

      (260,409)

      Accrued interest payable

       248,157

 

       220,137

      Other accrued liabilities

            (125)

 

         84,920

Net Cash Used in Operating Activities

      (908,650)

 

   (1,756,024)

Cash Flows from Investing Activities

   

Purchase of property and equipment

         (4,972)

 

       (69,122)

Change in other assets

               -   

 

         32,100

Net Cash Used in Investing Activities

         (4,972)

 

       (37,022)

Cash Flows from Financing Activities

   

Proceeds from borrowings under notes payable

       273,324

 

     1,723,487

Principal payments on notes payable and capital lease obligation

      (102,886)

 

      (332,929)

Proceeds from issuance of common stock and warrants

       822,423

 

       129,000

Proceeds from exercise of stock options

               -   

 

       275,000

Net Cash Provided by Financing Activities

       992,861

 

     1,794,558

Net Increase in Cash

         79,239

 

           1,512

Cash at Beginning of Year

           6,021

 

           4,509

Cash at End of Year

 $      85,260

 

 $        6,021






The accompanying notes are an integral part of these financial statements.


F-6





DIATECT INTERNATIONAL CORPORATION

STATEMENTS OF CASH FLOWS (CONTINUED)



For the Years Ended December 31,

2004

 

2003

Supplemental Disclosure of Cash Flow Information

   

Cash paid during the period for interest

 $     17,431

 

 $       46,033

Noncash Investing and Financing Activities

   

Conversion of notes and accrued interest into common stock

 $   416,973

 

 $     626,626

Conversion of accounts payable into common stock

      139,748

 

                -   

Satisfaction of accrued settlement obligations with common stock

        31,355

 

          41,648

Conversion of accounts payable into notes payable

      564,626

 

                -   

Conversion of royalties payable into notes payable

      113,623

 

                -   

Issuance of note payable upon purchase of land and building

              -   

 

        847,000

Principal payments on notes payable with cash in escrow

              -   

 

        400,000

Stock options exercised by reduction of notes payable

              -   

 

          35,000







The accompanying notes are an integral part of these financial statements.


F-7





NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


Organization and Description of Business – Diatect International Corporation (the “Company”) is a California corporation operating as a developer and marketer of pesticide products. It principally operates as a wholesale supplier of non-toxic pesticide products and grants credit to its customers, a substantial portion of which are retailers of agricultural products throughout the United States.


Use of Estimates – The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America and require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements. They may also affect the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates upon subsequent resolution of identified matters.


Business Condition The Company generated revenue of $665,676 and $732,391during the years ended December 31, 2004 and 2003, respectively. However, during the years ended December 31, 2004 and 2003, the Company incurred net losses of $2,818,583 and $5,162,155, respectively, and had negative cash flows from operating activities of $908,650 and $1,756,024, respectively. As of December 31, 2004, the Company had accumulated a deficit of $23,570,770, had a working capital deficiency of $3,101,961 and had a stockholders’ deficit of $2,637,879. The Company is also involved in several litigation claims. The Company’s cash resources consist of collections from customers, debt financing and from the issuance of common stock.


The Company’s ability to continue as a going concern is dependent upon its ability to obtain additional debt and equity capital sufficient to conduct its operations and to pay its obligations as they become due. Management plans to fund further operations of the Company through revenues generated from the sale of its pesticide product, from additional debt financing activities and from the issuance of common stock. Since December 31, 2004, the Company entered into a sale and leaseback transaction relating to its administrative office building and has issued common stock for cash, resulting in proceeds of $1,225,000.    An investor has expressed his intent to provide an additional $395,000 of equity financing to the Company as part of a subscription agreement with the Company to purchase a total of 3,500,000 shares of common stock for $700,000. The Company has entered into a memorandum o f understanding to acquire a corporation that may provide additional cash flows and has been granted a local vendor number from a major big box retailer to market the Company’s products throughout the southern United States. Management believes these sources will be sufficient to meet the Company’s operating needs; however, there can be no assurance.


Revenue Recognition – The Company recognizes revenue from the sale of its products upon receipt and acceptance by the customer and when collection can be reasonably estimated. Sales credits and price concessions are treated as a reduction of revenue. Product returns are permitted for up to 45 days, but these returns have been minor historically; therefore, the Company has been able to reasonably estimate returns and has accrued for product returns at the time of delivery.


Inventory – Inventory consists of raw materials and is valued at the lower of cost or market, cost being determined by the first-in-first-out method. Raw materials represent the various active ingredients that comprise the Company’s products. When there is evidence that inventory values are less than original cost, the inventory is reduced to market value. The Company determines market value based on current prices and whether obsolescence exists. During the years ended December 31, 2004 and 2003, inventory was written down by $0 and $463,861, respectively, to adjust the inventory to market value.




F-1





Other Assets: EPA Labels – EPA Labels is an intangible asset that represents the costs incurred by the Company in order to register its insecticide products with the United States Environmental Protection Agency pursuant to the Federal Insecticide, Fungicide and Rodenticide Act. During 2003, the Company determined to amortize the EPA Labels over their 7-year estimated life using the straight-line method.


Fair Value of Financial Instruments – Due to the short maturity of trade receivables and current liabilities, including trade payables, the carrying amount approximates fair value. The carrying amount reported for notes payable approximates fair value due to the interest rates on these notes approximating current interest rates available to the Company given their current business condition.


Basic and Diluted Loss Per Share – Basic loss per share is computed by dividing the net loss by the weighted average number of shares outstanding during the year. At December 31, 2004 and 2003, there were potentially issuable common shares outstanding relating to convertible notes payable and warrants to purchase or receive 4,495,050 shares and 1,259,593 shares of common stock, respectively, that were not included in the computation of diluted net loss per share as their effect would have been anti-dilutive, thereby decreasing the net loss per common share.


Advertising and Promotion Expenses – Advertising and promotion expenses include the costs incurred in the design, development, and printing of Company literature, marketing materials and expenses incurred in efforts to promote the Company’s product. In the process of finding new distributors, the Company’s in-house sales force attended a number of regional trade shows. The Company expenses all advertising and promotion expenditures as incurred.


Stock-Based Compensation Plans -The Company accounts for its stock-based compensation issued to non-employees using the fair value method in accordance with SFAS No. 123, “Accounting for Stock-Based Compensation.” Under SFAS No. 123, stock-based compensation is determined as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable.  The measurement date for these issuances is the date that the securities were issued, which approximates the date at which a commitment for performance by the recipient to earn the equity instruments is reached or the date at which the recipient’s performance is complete.


At December 31, 2004, the Company did not have any stock-based employee compensation plans. The Company has accounted for stock options granted in the past under the recognition method and measurement principles of APB Opinion No. 25, Accounting for Stock Issued to Employees, and the related interpretations. Under APB Opinion No. 25, compensation related to stock options, if any, is recorded if an option’s exercise price on the measurement date is below the fair value of the Company’s common stock, and amortized to expense over the vesting period.  Compensation expense for stock awards or purchases, if any, is recognized if the award or purchase price on the measurement date is below the fair value of the Company’s common stock, and is recognized on the date of award or purchase.  These accounting policies resulted in the Company not recognizing any stock-based employee compensat ion cost during the years ended December 31, 2004 or 2003. The effect on net loss and net loss per common share if the Company had applied the fair value recognition provisions of SFAS No. 123 to employee stock-based compensation would have resulted in no difference from reported amounts.




F-2





Recent Accounting Pronouncements – In December 2004, the FASB issued Statement No. 123 (Revised 2004), Share-Based Payment (“Statement 123(R)”). Statement 123(R) revises Statement No. 123, Accounting for Stock-Based Compensation, and supersedes APB Opinion No. 25, Accounting for Stock Issued to Employees. Statement 123(R) requires the recognition of the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest. Under the modified-prospective basis alternative, which has been selected by the Company to adopt Statement 123(R), the Company is required to adopt Statement 123(R) on January 1, 2006 and the Company will recognize employee compensation from stock options and awards equal to their unamortized grant-date fair value over their re maining vesting period. As of December 31, 2004, the Company does not have any stock options outstanding; therefore adopting Statement 123(R) is not expected to have any effect on the Company’s future financial position or results of operations unless additional stock options or awards occur.


In December 2004, the FASB issued SFAS Statement No. 153, Exchanges of Non-monetary Assets—an amendment of APB Opinion No. 29. This Statement amends APB Opinion 29 to eliminate the exception for non-monetary exchanges of similar productive assets and replaces it with a general exception for exchanges of non-monetary assets that do not have commercial substance. A non-monetary exchange has commercial substance if the future cash flows of the entity are expected to change significantly as a result of the exchange. The statement will be effective in January 2006. The Company does not expect that the adoption of SFAS No. 153 will have a material impact on its financial statements.


In November 2004, the FASB issued SFAS No. 151, Inventory Costs. Statement 151 clarifies the accounting for abnormal amounts of idle facility expense, freight, handling costs, and wasted material (spoilage).  The Company will be required to apply this statement to inventory costs incurred after December 31, 2005.  The adoption of this standard is not expected to have a material effect on the Company’s financial position or results of operations.


In May 2003, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 150, Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity (Statement 150). Statement 150 establishes standards for classifying and measuring certain financial instruments with characteristics of both liabilities and equity and requires that those instruments be classified as liabilities in statements of financial position. Previously, many of those instruments were classified as equity.  Adoption of Statement 150 had no impact on the financial position of the Company.





F-3





Restatement of 2003 Financial Statements – The Company has restated its financial statements as of December 31, 2003 and for the year then ended as follows:


 

 As Previously

 

 Effect of

  

 

 Reported

 

 Restatement

 

 As Restated

For the Year Ended December 31, 2003

     

Cost of revenue

 $     345,782

 

 $         62,967

 

 $     408,749

Adjustment of inventory to market value

                  -   

 

          463,861

 

        463,861

Expenses

     3,080,650

 

          565,527

 

     3,646,177

Interest expense

     1,808,137

 

         (419,639)

 

     1,388,498

Gain from sale of mining property interests

   12,000,000

 

    (12,000,000)

 

                  -   

Net income (loss)

     7,524,054

 

    (12,686,209)

 

    (5,162,155)

Basic income (loss) per share

              0.15

 

               (0.26)

 

             (0.11)

      

As of December 31, 2003

     

Current assets

 $  1,154,497

 

 $      (367,678)

 

 $     786,819

Note receivable from related party

   12,000,000

 

    (12,000,000)

 

                  -   

Intangible assets

     1,744,822

 

         (256,500)

 

     1,488,322

Total assets

   16,026,663

 

    (12,638,712)

 

     3,387,951

Current liabilities

     1,580,912

 

       2,517,871

 

     4,098,783

Long-term liabilities

     4,446,121

 

      (2,504,599)

 

     1,941,522

Stockholders' equity (deficit)

     9,999,630

 

    (12,651,984)

 

    (2,652,354)


 The following is a summary of the significant reasons for the restatement:

·

The sale of mining property for a $12,000,000 note receivable was not substantive and was reversed.

·

Inventory was adjusted by $463,861 to reduce it to market value which was lower than cost.

·

A portion of common stock issued for consulting services was recognized as a prepaid consulting expense of $111,000.

·

Intangible assets relating to EPA labels were revised from having an indefinite life to being amortized over their estimated useful life of seven years, which resulted in recognition of $248,000 of amortization expense.

·

Approximately $1,400,000 of notes payable were reclassified from long-term liabilities to current liabilities.

·

Accrued interest payable was decreased by an over-accrual in the amount of approximately $380,000.

·

General and administrative expense was increased for unrecorded liabilities of approximately $200,000.

·

Stock options and warrants, which had expired or had been exercised, of $210,635 were reclassified to common stock.

·

Common stock subscribed in the amount of $75,000 was reversed as it did not relate to valid subscription agreements.

·

The fair value of stock options issued to a consultant of $184,730 was recognized as consulting expense.

·

Products that had been contributed to an agricultural organization to promote the Company’s products had been recognized as bad debt expense in the amount of $289,000. The related expense was reclassified to advertising and promotion expense.





F-4





NOTE 2 – PROPERTY, PLANT AND EQUIPMENT


Property, plant and equipment are stated at cost. Expenditures for normal repairs and maintenance are charged to operations as incurred. The cost of an asset and related accumulated depreciation are also charged to operations when retired or otherwise disposed. Depreciation is computed based on the estimated useful life of the assets using straight-line and accelerated methods. Depreciation expense for the years ended December 31, 2004 and 2003 was $87,703 and $91,877, respectively. The components of property, plant and equipment were as follows:


 

Estimated

   
 

Useful Life in

   

December 31,

Years

2004

 

2003

Land

 

     150,000

 

     150,000

Building

30

     725,500

 

     725,500

Computer equipment

3 to 5

 $    88,437

 

 $    97,630

Office furniture and equipment

5

       33,275

 

       33,275

Manufacturing equipment

5 to 10

     245,610

 

     262,895

Total Property and Equipment

 

   1,242,822

 

   1,269,300

Less: Accumulated depreciation

 

    (233,499)

 

    (156,490)

Total Property and Equipment

 

 $1,009,323

 

 $1,112,810



NOTE 3 – NOTES PAYABLE


December 31,

2004

 

2003

Revolving lines of credit with financial institutions

 $      15,404

 

 $      16,358

Mortgage note payable

       847,000

 

       847,000

Convertible debenture with La Jolla Investment, LLC

       286,263

 

       250,000

Unsecured, 8% notes payable to investors

               -   

 

         20,000

Unsecured, 10% notes payable to investors

       392,155

 

     1,482,814

Unsecured, 12% notes payable to investors

       366,685

 

       661,661

Unsecured, 15% notes payable to investors

       260,000

 

       278,070

5% notes payable due in 2008

     1,277,057

 

               -   

5% notes payable to vendors due in 2008

       508,506

 

               -   

Interest-bearing cash advance

         97,000

 

         97,000

Non-interest cash advances

           7,700

 

               -   

Total Notes Payable

     4,057,770

 

     3,652,903

Less current portion of notes payable

   (2,272,207)

 

   (1,711,381)

Total Long-Term Notes Payable.

 $  1,785,563

 

 $  1,941,522



Revolving Lines of Credit – The Company has three unsecured, revolving credit notes with lending institutions, two of which have available credit lines of $2,500 each bearing interest at 8.5% and a third with $10,000 of available credit that bears interest at 16%. The balances due to the lenders are in excess of the available credit limits at December 31, 2004.





F-5





Mortgage Note Payable – The Company purchased its facilities on January 17, 2003 at a total cost of $875,500.  Terms of the agreement called for a down payment of $28,500 and a mortgage note of $847,000 bearing interest at a rate of 13% per annum and secured by the related land and building. Interest only payments commenced on February 17, 2003 and will continue on the same day of each succeeding month until January 17, 2005 at which time the mortgage is due.  Interest only payments are approximately $9,200 per month.  The $847,000 mortgage note payable is reflected on the balance sheet under short-term debt at December 31, 2004. During March 2005, the land and building were sold to an unrelated third party and the proceeds from the sale were use to satisfy the balance due under the mortgage note and other short-term liabilities.  


La Jolla Cove Investors, Inc. – During December 2002, the Company entered into a convertible debenture agreement with La Jolla Cove Investors, Inc., who at the time was the named underwriter (the “Underwriter”) for a planned public offering of the Company’s common stock. The Underwriter advanced the Company $150,000 in 2002 and $100,000 in 2003, which advances were evidenced by a convertible debenture agreement that was to be repaid out of a portion of the proceeds from the public offering. On July 12, 2004, the Underwriter filed a complaint for breach of contract in the State of California claiming a default under the terms of the convertible debenture in the amount of $406,990. On November 18, 2004, prior to the registration statement relating to the public offering being declared effective, the Company withdrew the registration statement. The Underwriter has agreed to s tay all collection efforts pursuant to the complaint until April 14, 2005 and a settlement offer of $230,000 is currently being negotiated. The Company has recorded a liability relative to the convertible debenture agreement of $268,132 in its 2004 financial statements.


Unsecured Convertible and Non-Convertible Notes Payable – The Company has borrowed money from several entities with the various terms including demand promissory notes. The notes are unsecured and bear interest at rates from 5% to 15% payable at different times. As additional consideration for the loans, the Company issued its common stock to the investors based on the principal amount loaned. The shares of common stock issued to the investors were valued at the market value of the common stock on the date issued and were recognized as interest expense on that date. During the year ended December 31, 2004, the Company issued 2,736,565 shares of common stock at prices ranging from $0.06 to $0.20 per share, having a total market value of $354,106, for these financing incentives and for loan guarantees. During the year ended December 31, 2003, the Company issued 6,498,732 shares of common stock at prices ranging from $0.10 to $0.24 per share, having a total market value of $1,000,617, for these financing incentives and for loan guarantees.

 

During the year ended December 31, 2004, promissory notes that were not previously convertible were modified to make them convertible and the Company issued 4,831,013 shares of common stock valued between $0.05 to $0.23 per share upon conversion of $416,973 of notes payable which includes $40,035 of accrued interest. During the year ended December 31, 2003, similar modifications occurred to promissory notes and the Company issued 2,711,802 shares of common stock valued between $0.15 to $0.32 per share upon conversion of $626,626 of notes payable which includes $103,254 of accrued interest. The effective conversion prices were in excess of the market value of the common stock on the dates issued, thus the investors did not receive beneficial conversion options.


At December 31, 2004 and 2003, $25,000 and $277,300 of promissory notes, respectively, and related unpaid accrued interest were convertible at the option of the investor into common stock at prices ranging $0.20 to $0.25 per share. At December 31, 2004 and 2003, the convertible promissory notes were convertible into 126,300 shares and 1,259,593 shares, respectively.





F-6





Cash Advance – In 2003, a shareholder used a personal line of credit to advance cash to the Company.  The Company has obligated itself to issue this shareholder 250,000 shares of its common stock every six months for the use of this line of credit, which is unsecured, bears no interest and has no stated maturity date. During 2005, the Company issued a total of 750,000 shares of common stock to this shareholder in payment of the use of the line of credit.


5% Notes Payable – In 2004 several note holders signed new promissory notes extending the terms of their notes to become due in 2008 and accrue interest at a new annual rate of 5%.


Notes Payable to Vendors – In 2004 vendors agreed to extend the terms of outstanding accounts payables by converting them into long-term promissory notes that accrue interest at 5% per annum.


NOTE 4 – INCOME TAXES


Income taxes are provided based upon the liability method of accounting pursuant to SFAS No. 109, Accounting for Income Taxes.  Under this approach, deferred income taxes are recorded to reflect the tax consequences on future years of differences between the tax basis of assets and liabilities and their financial reporting amounts at each year-end.  A valuation allowance is recorded against deferred tax assets if management does not believe the Company has met the "more likely than not" standard imposed by SFAS No. 109. The tax effects of temporary differences and carry forwards which give rise to the deferred income tax assets as of December 31, 2004 and 2003 are as follows:


 

 

2004

 

2003

Net operating loss carry forwards:

Federal

 $ 7,198,103

 

 $ 6,268,084

 

State

    1,114,257

 

       970,292

Impairment of inventory

 

       173,020

 

       173,020

Allowance for bad debt

 

        15,183

 

        32,940

Total deferred income tax assets

 

    8,500,563

 

    7,444,336

Valuation allowance

 

   (8,435,445)

 

   (7,392,352)

Deferred income tax liability - amortization

 

       (65,118)

 

       (51,984)

Net deferred income tax assets

 

 $            -   

 

 $            -   



A reconciliation of the income tax expense from continuing operations and the amount that would be computed using statutory federal income tax rates is as follows:


For the Years Ended December 31,

2004

 

2003

Federal tax benefit

 $    (958,318)

 

 $ (1,755,133)

State tax benefit,  net of federal effect

         (93,013)

 

       (170,351)

Non-deductible items

            8,237

 

          89,283

Change in valuation allowance

      1,043,094

 

      1,836,201

Income tax benefit

 $              -   

 

 $             -   






F-7





At December 31, 2004, the Company has net operating loss carry forwards of approximately $22 million, which expire in the years 2011 through 2024.  



NOTE 5 – LITIGATION AND ACCRUED SETTLEMENT OBLIGATIONS


Accrued settlement obligations accrued by the Company are from settled and pending law suits and consist of the following:


December 31,

2004

 

2003

Futura Title Corporation

 $          -   

 

 $  106,619

Litho-Flexo

      72,625

 

      72,625

L. Craig Hunt

            -   

 

      60,544

David J. Stecher

      16,814

 

            -   

Iver J. Longtieg

            -   

 

      21,275

Compax/Flex-Pak

    220,000

 

            -   

Others

    109,102

 

      76,166

Total Accrued Obligations

 $  418,541

 

 $  337,229



Futura Title Corporation - A settlement obligation of $106,620 payable to Futura Title Corporation was accrued at December 31, 2003, and reclassified to a note payable during 2004.


Litho-Flexo Grafics, Inc. – The Company claims that this vendor provided defective labels to be used in the packaging of its products and therefore did not pay outstanding invoices in the amount of $72,625. The vendor filed a complaint claiming an amount of $92,478 is due and the Company counterclaimed for damages resulting from the use of the defective labels in excess of $100,000. The Company continues to carry the $72,625 on its financial statements for 2003 and 2004 as a liability.


L. Craig Hunt – Pursuant to the non-payment of a $42,750 promissory note dated August 28, 1996, a judgment was entered against the Company on February 1, 1999 in the amount of $61,543. The plaintiff did not pursue the collection of this judgment and the Company recorded this amount as a gain from extinguishment of debt during 2004. During 2005 the Plaintiff’s estate made demand on the Company for payment of the judgment amount. The Company contends that the period allowed for the collection of the judgment had expired and no further obligation exists.


David J. Stecher – On December 18, 2002 the Company issued an $18,070 promissory note to David J. Stecher, due on demand with interest at 15% per annum. Subsequently the Company made payments reducing the balance for both principal and interest to $16,814. This claim is for the entire principal amount of the note.  In the Company’s financial statements for 2004, a liability in the amount of $16,814 is recorded.


Iver J. Longeteig – An obligation that resulted from litigation was satisfied by cash payments in the amount of $6,844 during 2003 and the issuance of 115,000 shares of common stock during 2004, valued at $21,275, or $0.19 per share which was the market value of the common stock on the date of the issuance.





F-8





Complete Packaging, LLC d.b.a. Compax – On December 2, 2004, a judgment was entered against the Company in the amount of $323,892 plus accrued interest from November 30, 2004. During 2005, the Company entered into a settlement agreement in which the Company agreed to make three $25,000 payments through May 2005 and a lump sum payment of $145,000 in June, 2005.


Bruce L. Shannon – On August 1, 2001, the Company executed a $200,000 note payable with interest at the rate of 12% per annum, due August 1, 2002 and subsequently extended to May 1, 2005. Mr. Shannon filed suit claiming that this note was not extended. In the Company’s financial statements for 2004, a note payable in the amount of $200,000 and accrued interest in the amount of $80,500 has been recorded.


Robinson Family LLC – On October 1, 2001, the Company executed a $106,000 promissory note bearing interest at 12% per annum that was due on April 1, 2002. The plaintiff filed suit to collect this note and accrued interest. The Company is in the process of negotiating a settlement of the note. The note payable is carried at $126,686 at December 31, 2004.


Jared G. Parkinson – Parkinson filed a complaint for $10,000 claiming that the amount of an outstanding note payable is due. The Company contends that a $2,500 payment has been made and that only $7,500 plus accrued interest of $1,334 is due. In the Company’s financial statements for 2004, a liability for $8,834 has been recorded.


John Chaney – A former employee of the Company has filed a breach of contract claim against the Company in the amount of $6,251. The Company has not accrued any liability for this claim and intends to contest the suit.


NOTE 6 - COMMON STOCK


During the year ended December 31, 2003, the Company issued 4,373,962 shares of its common stock valued at $819,815 for current and future services from directors and employees.  The shares were valued at their market value on the date of issuance.  The Company also issued 580,000 shares of its common stock for $109,000 in cash, or $0.19 per share.  In addition, the Company issued 2,350,000 shares of its common stock upon the exercise of stock options for $310,000.  Also, 350,000 shares of common stock valued at $41,648 were issued as partial payment of an accrued settlement obligation.    


During the year ended December 31, 2004, the Company issued 10,848,356 shares of its common stock valued at $1,068,443 for current and future services, as well as 948,574 shares of common stock valued at $139,748 in satisfaction of existing account payable.  The shares were valued at their market value on the date of issuance.  The Company also issued 4,473,600 shares of its common stock for $589,500 in cash, or $0.13 per share.  Also, 189,000 shares of common stock valued at $31,455 were issued as partial payment of an accrued settlement obligation.    


During 2004, the Company issued 2,912,500 shares of common stock, warrants to purchase 2,912,500 shares of common stock at $0.20 per share and warrants to purchase 1,456,250 shares of common stock at $0.35 per share for net proceeds of $232,923. The proceeds were allocated to the common stock and the warrants base upon their relative fair value, with $84,890 allocated to the common stock, $100,631 allocated to the $0.20 warrants and $47,402 allocated to the $0.35 warrants. The fair value of the warrants was determined by the Black-Scholes Option Pricing Model. The fair value of the $0.20 and the $0.35 warrants was $295,079 and $138,991, respectively, based upon the following assumptions: risk-free interest rates of 3.0%, expected dividend yield of 0%, expected volatility of 172% and expected life of 3 years.





F-9





NOTE 7 - STOCK OPTIONS AND WARRANTS


During 2003, the Company authorized and issued 2,000,000 options to a consultant who exercised those options during the same year at an average exercise price of $0.14 per share. The fair value of these options was $184,730. The fair value was computed using the black-scholes pricing model using the following weighted average assumptions: volatility of 184%, interest rate of 1.0% and an estimated life of six months. During 2003, an officer of the Company exercised an option to acquire 350,000 shares of common stock at a price of $0.10 per share pursuant to the Company’s 1995 employees’ stock option plan. During 2003 the remaining 150,000 options under the 1995 employees’ stock option plan were forfeited.


In November 2002, the Company adopted the Diatect International Corporation 2002 Stock Option and Award Plan (the "Plan") under which 3,000,000 shares of common stock are available for issuance. As of December 31, 2002, the Company had issued options for 2,000,000 shares of common stock to officers of the Company. During 2003 the Company renegotiated its employment agreements with those officers and the remaining options outstanding were terminated.


The following summarizes the stock option activity for the year ended December 31, 2003:


  

Weighted Average Per Share

  

 

Shares

Outstanding at December 31, 2002

         2,500,000

 $     0.16

Granted

         2,000,000

 $     0.14

Exercised

        (2,350,000)

 $     0.13

Expired/Forfeited

        (2,150,000)

 $     0.17

Outstanding at December 31, 2003

                    -   

 $        -   

Exercisable at December 31, 2003

                    -   

 

Weighted average fair value of options granted during 2003

 $     0.13






F-10





The following summarizes the warrant activity for the year ended December 31, 2004:


  

 Weighted Averaaage

 

Exercise

 Number  

 Remaining Contractual

Number

Prices

 Outstanding

  Life (Years)

Exercisable

$0.20

   2,912,500

2.5

  2,912,500

$0.35

   1,456,250

2.5

  1,456,250

$0.20 - $0.35

   4,368,750

2.5

  4,368,750



NOTE 8 – CONTINGENCIES


The production of pesticides is subject to complex environmental regulations. As of the date of these financial statements and the date of this report, the Company is unaware of any pending environmentally related litigation or of any specific past or prospective matters involving environmental concerns that could impair the marketing of its products.


NOTE 9 - RELATED PARTY TRANSACTIONS


A Director performed legal services for the Company during the years ended December 31, 2004 and 2003. During 2004, 43,750 shares of common stock valued at market ($7,875) were issued for these services. During 2003, 378,322 shares of common stock valued at market ($56,748) were issued for these services.


Certain directors of the Company have extended their credit and guarantees on behalf of the Company. During 2004 and 2003, the Company issued 400,000 shares of common stock valued at $60,000 and 700,000 shares of common stock valued at $105,000, respectively, to compensate these directors. These shares were valued at market on the dates issued.


NOTE 10 - SALE OF MINING PROPERTY


The Company owns 35 160-acre association placer diatomaceous earth mining claims and 48 20-acre placer diatomaceous earth mining claims covering almost 11 square miles located in the State of Oregon. The Company has not engaged in any mining operations and does not anticipate undertaking mining operations. The property is carried in the accompanying financial statements at no cost.

 

On August 12, 2003, the Company received a letter of intent from Diatomaceous Earth Deposits of Virginia to purchase 90% of the diatomaceous earth mining site in Oregon in exchange for a note in the amount of $31.1 million. An agreement for the sale of the property interest was completed on September 10, 2003 by the buyer executing a promissory note in the amount of $31.1 million. The terms of the note require an annual principal payment of $1,945,350 and interest at 8% per annum for 16 years commencing in September 2005. Diatomaceous Earth Deposits of Virginia is co-owned by Michael P. McQuade who is an outside director of the Company.  The Company has considered the agreement to be non-substantive as the buyer is thinly capitalized and has only made minimal investments in the property.




F-11





The Company therefore did not recognize the sale. In December 2004, it was mutually agreed that even though the purchaser had spent money to investigate the potential of placing the mining claims into production, such efforts would not be pursued and the Company entered into a termination and release agreement with the purchaser.


NOTE 11 - SUBSEQUENT EVENTS


On March 9, 2005, the Company entered into a memorandum of understanding with Paul Morrell, Inc., d.b.a. The Event Source (“TES”). Under the terms of the memorandum of understanding as subsequently modified, the Company agreed to purchase the business operations and the intangible assets of TES in consideration of an $80,000,000 promissory note bearing interest at 3% per annum, due in 2012. The purchase is subject to several conditions precedent to closing.


On March 9, 2005 the Company sold its real property located in Heber City, Utah, for $900,000 and recognized a gain of approximately $50,000.


Subsequent to December 31, 2004, the Company has issued 1,925,000 shares of common stock for cash in the amount of $325,000.





F-12











                   CERTIFICATIONS


I, David H Andrus, certify that:


1. I have reviewed this Annual report on Form 10-KSB of Diatect International Corporation;

2. Based on my knowledge, this Annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have: a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; b) evaluated the effectiveness of the registrant's disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the "Evaluation Date"); and c) presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function); a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant's ability to record, process, summarize and report financial data and have identified for the registrant's auditors any material weaknesses in internal controls; and b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control.

6. The registrant's other certifying officers and I have indicated in this quarterly report whether of not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.


Date: April 15, 2005                              /S/David H Andrus

                                                 Principal Executive Officer

                                                 Principal Financial Officer



















CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



Each of the undersigned hereby certifies, in his/her capacity as an officer of Diatect International Corporation (the “Company”), for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:


1.

the Annual Report of the Company on Form 10-KSB for the year ended December 31, 2004, fully complies with the requirements of Section 13(a) and/or 15(d) of the Securities Exchange Act of 1934, as applicable; and


2.

the information contained in such report fairly presents, in all material respects, the financial condition and results of operation of the Company.



Dated:  April 15, 2004

By:

/s/ David H Andrus________

Name:

        David H Andrus,

Title:

Principal Executive Officer,

Principal Financial Officer





Exhibit 99.1


Code of Ethics and Business Conduct for Officers, Directors and Employees of


DIATECT INTERNATIONAL CORPORATION


1.  Treat in an Ethical Manner Those to Whom DIATECT INTERNATIONAL CORPORATION Has an Obligation


We are committed to honesty, just management, fairness, providing a safe and healthy environment free from the fear of retribution, and respecting the dignity due everyone.


For the communities in which we live and work we are committed to observe sound environmental business practices and to act as concerned and responsible neighbors, reflecting all aspects of good citizenship.


For our shareholders we are committed to pursuing sound growth and earnings objectives and to exercising prudence in the use of our assets and resources.


2.  Promote a Positive Work Environment


All employees want and deserve a workplace where they feel respected, satisfied, and appreciated. We respect cultural diversity and recognize that the various communities in which we may do business may have different legal provisions pertaining to the workplace. As such, we will adhere to the limitations specified by law in all of our localities, and further, we will not tolerate harassment or discrimination of any kind -- especially involving race, color, religion, gender, age, national origin, disability, and veteran or marital status.


Providing an environment that supports honesty, integrity, respect, trust, responsibility, and citizenship permits us the opportunity to achieve excellence in our workplace. While everyone who works for the Company must contribute to the creation and maintenance of such an environment, our executives and management personnel assume special responsibility for fostering a work environment that is free from the fear of retribution and will bring out the best in all of us. Supervisors must be careful in words and conduct to avoid placing, or seeming to place, pressure on subordinates that could cause them to deviate from acceptable ethical behavior.


3.  Protect Yourself, Your Fellow Employees, and the World We Live In


We are committed to providing a drug-free, safe, and healthy work environment, and to observe environmentally sound business practices. We will strive, at a minimum, to do no harm and where possible, to make the communities in which we work a better place to live. Each of us is responsible for compliance with environmental, health, and safety laws and regulations. Observe posted warnings and regulations. Report immediately to the appropriate management any accident or injury sustained on the job, or any environmental or safety concern you may have.


4.  Keep Accurate and Complete Records


We must maintain accurate and complete Company records.  Transactions between the Company and outside individuals and organizations must be promptly and accurately entered in our books in accordance with generally accepted accounting practices and principles.  No one should rationalize or even consider misrepresenting facts or falsifying records. It will not be tolerated and will result in disciplinary action.


5.  Obey the Law


We will conduct our business in accordance with all applicable laws and regulations.  Compliance with the law does not comprise our entire ethical responsibility. Rather, it is a minimum, absolutely essential condition for performance of our duties.  In conducting business, we shall:

 

a.

Strictly Adhere to All Antitrust Laws


Officer, directors and employees must strictly adhere to all antitrust laws.  Such laws exist in the United States, the European Union, and in many other countries where the Company may conduct business.  These laws prohibit practices in restraint of trade such as price fixing and boycotting suppliers or customers.  They also bar pricing intended to run a competitor out of business; disparaging, misrepresenting, or harassing a competitor; stealing trade secrets; bribery; and kickbacks.


b.

Strictly Comply with All Securities Laws


In our role as a publicly owned company, we must always be alert to and comply with the security laws and regulations of the United States and other countries.


i.

Do Not Engage in Speculative or Insider Trading


Federal law and Company policy prohibits officers, directors and employees, directly or indirectly through their families or others, from purchasing or selling company stock while in the possession of material, non-public information concerning the Company.  This same prohibition applies to trading in the stock of other publicly held companies on the basis of material, non-public information. To avoid even the appearance of impropriety, Company policy also prohibits officers, directors and employees from trading options on the open market in Company stock under any circumstances.


Material, non-public information is any information that could reasonably be expected to affect the price of a stock.  If an officer, director or employee is considering buying or selling a stock because of inside information they possess, they should assume that such information is material. It is also important for the officer, director or employee to keep in mind that if any trade they make becomes the subject of an investigation by the government, the trade will be viewed after-the-fact with the benefit of hindsight. Consequently, officers, directors and employees should always carefully consider how their trades would look from this perspective.


Two simple rules can help protect you in this area: (1) Don=t use non-public information for personal gain. (2) Don't pass along such information to someone else who has no need to know.


This guidance also applies to the securities of other companies for which you receive information in the course of your employment at DIATECT INTERNATIONAL CORPORATION


ii.

Be Timely and Accurate in All Public Reports


As a public company, Drilling, Inc must be fair and accurate in all reports filed with the United States Securities and Exchange Commission.  Officers, directors and management of Drilling, Inc are responsible for ensuring that all reports are filed in a timely manner and that they fairly present the financial condition and operating results of the Company.  


Securities laws are vigorously enforced.  Violations may result in severe penalties including forced sales of parts of the business and significant fines against the Company. There may also be sanctions against individual employees including substantial fines and prison sentences.


The Chief Executive Officer and Chief Financial Officer will certify to the accuracy of reports filed with the SEC in accordance with the Sarbanes-Oxley Act of 2002.  Officers and Directors who knowingly or willingly make false certifications may be subject to criminal penalties or sanctions including fines and imprisonment.


6.  Avoid Conflicts of Interest


Our officers, directors and employees have an obligation to give their complete loyalty to the best interests of the Company.  They should avoid any action that may involve, or may appear to involve, a conflict of interest with the company.  Officers, directors and employees should not have any financial or other business relationships with suppliers, customers or competitors that might impair, or even appear to impair, the independence of any judgment they may need to make on behalf of the Company.  


Here are some ways a conflict of interest could arise:


_

Employment by a competitor, or potential competitor, regardless of the nature of the employment, while employed by DIATECT INTERNATIONAL CORPORATION


_

Acceptance of gifts, payment, or services from those seeking to do business with DIATECT INTERNATIONAL CORPORATION


_

Placement of business with a firm owned or controlled by an officer, director or employee or his/her family.


_

Ownership of, or substantial interest in, a company that is a competitor, client or supplier.


_

Acting as a consultant to a Drilling, Inc customer, client or supplier.


_

Seeking the services or advice of an accountant or attorney who has provided services to DIATECT INTERNATIONAL CORPORATION


Officers, directors and employees are under a continuing obligation to disclose any situation that presents the possibility of a conflict or disparity of interest between the officer, director or employee and the Company.  Disclosure of any potential conflict is the key to remaining in full compliance with this policy.


7.  Compete Ethically and Fairly for Business Opportunities


We must comply with the laws and regulations that pertain to the acquisition of goods and services.  We will compete fairly and ethically for all business opportunities.  In circumstances where there is reason to believe that the release or receipt of non-public information is unauthorized, do not attempt to obtain and do not accept such information from any source. If you are involved in Company transactions, you must be certain that all statements, communications, and representations are accurate and truthful.


8.  Avoid Illegal and Questionable Gifts or Favors


The sale and marketing of our products and services should always be free from even the perception that favorable treatment was sought, received, or given in exchange for the furnishing or receipt of business courtesies.  Officers, directors and employees of Drilling, Inc will neither give nor accept business courtesies that constitute, or could be reasonably perceived as constituting, unfair business inducements or that would violate law, regulation or policies of the Company, or could cause embarrassment to or reflect negatively on the Company’s reputation.


9.  Maintain the Integrity of Consultants, Agents, and Representatives


Business integrity is a key standard for the selection and retention of those who represent DIATECT INTERNATIONAL CORPORATION Agents, representatives, or consultants must certify their willingness to comply with the Company’s policies and procedures and must never be retained to circumvent our values and principles.  Paying bribes or kickbacks, engaging in industrial espionage, obtaining the proprietary data of a third party without authority, or gaining inside information or influence are just a few examples of what could give us an unfair competitive advantage and could result in violations of law.


10  Protect Proprietary Information


Proprietary Company information may not be disclosed to anyone without proper authorization.  Keep proprietary documents protected and secure. In the course of normal business activities, suppliers, customers, and competitors may sometimes divulge to you information that is proprietary to their business.  Respect these confidences.


11.  Obtain and Use Company Assets Wisely


Personal use of Company property must always be in accordance with corporate policy.  Proper use of Company property, information resources, material, facilities, and equipment is your responsibility.  Use and maintain these assets with the utmost care and respect, guarding against waste and abuse, and never borrow or remove Company property without management's permission.


12.  Follow the Law and Use Common Sense in Political Contributions and Activities


Drilling, Inc encourages its employees to become involved in civic affairs and to participate in the political process.  Employees must understand, however, that their involvement and participation must be on an individual basis, on their own time, and at their own expense.  In the United States, federal law prohibits corporations from donating corporate funds, goods, or services, directly or indirectly, to candidates for federal offices -- this includes employees' work time. Local and state laws also govern political contributions and activities as they apply to their respective jurisdictions, and similar laws exist in other countries.


13.  Board Committees.


The Company shall establish an Audit Committee, at the appropriate time, empowered to enforce this Code of Ethics.  The Audit Committee will report to the Board of Directors at least once each year regarding the general effectiveness of the Company’s Code of Ethics, the Company’S controls and reporting procedures and the Company’s business conduct.


14.  Disciplinary Measures.


The Company shall consistently enforce its Code of Ethics and Business Conduct through appropriate means of discipline. Violations of the Code shall be promptly reported to the Audit Committee.  Pursuant to procedures adopted by it, the Audit Committee shall determine whether violations of the Code have occurred and, if so, shall determine the disciplinary measures to be taken against any employee or agent of the Company who has so violated the Code. The disciplinary measures, which may be invoked at the discretion of the Audit Committee, include, but are not limited to, counseling, oral or written reprimands, warnings, probation or suspension without pay, demotions, reductions in salary, termination of employment and restitution. Persons subject to disciplinary measures shall include, in addition to the violator, others involved in the wrongdoing such as (i) persons who fail to use reasonable care to detect a violation, (ii) persons who if requested to divulge information withhold material information regarding a violation, and (iii) supervisors who approve or condone the violations or attempt to retaliate against employees or agents for reporting violations or violators.

 






























-----END PRIVACY-ENHANCED MESSAGE-----